Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and Cash Equivalents $ 1,175 $ 862
Accounts Receivable, Net of Allowances of $150 at both March 31, 2024 and December 31, 2023 761 1,004
Inventory 1,663 1,700
Prepaid Expenses & Other Assets 589 470
Notes Receivable 650 645
Assets Related to Discontinued Operations 16 12
Total Current Assets 4,854 4,693
Property, Equipment and Leasehold Improvements, Net 9,690 9,766
Operating Lease Right-of-Use Assets 8,508 8,965
Total Intangible Assets, Net 1,350 1,359
Goodwill 3,585 3,585
Other Assets 2,824 1,541
Investments 1,083 2,067
Long-Term Assets Related to Discontinued Operations 69 95
TOTAL ASSETS 31,963 32,071
Current Liabilities:    
Accounts Payable & Accrued Liabilities 26,067 23,218
Current Portion of Notes Payable 22,573 22,593
Income Taxes Payable 17,076 16,637
Liabilities Related to Discontinued Operations 0 100
Total Current Liabilities 65,716 62,548
Notes Payable, Net of Discounts 6,472 6,485
Deferred Tax Liabilities 140 112
Operating Lease Liabilities 8,272 8,622
Long-Term Liabilities Related to Discontinued Operations 0 0
TOTAL LIABILITIES 80,600 77,767
COMMITMENTS AND CONTINGENCIES (Note 18)
STOCKHOLDERS’ DEFICIT:    
Preferred Stock, Convertible Series V, par value $0.001: 25,000,000 shares authorized; 14,071,431 shares outstanding as of March 31, 2024 and December 31, 2023 1 1
Common Stock, par value $0.001: 990,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 8,499,105 and 8,509,384 shares outstanding as of March 31, 2024 and December 31, 2023, respectively 8 9
Additional Paid-In Capital 408,584 408,473
Accumulated Deficit (457,230) (454,179)
TOTAL STOCKHOLDERS’ DEFICIT (48,637) (45,696)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 31,963 $ 32,071